| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Laboratory of Immunology, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; and the 2 Department of Ophthalmology, Jichi Medical School, Tochigi, Japan.
PURPOSE. To elucidate the role of draining cervical lymph nodes (CLNs) in corneal alloimmunity.
METHODS. Fully mismatched orthotopic corneal transplantation was performed in BALB/c hosts that had their CLNs excised before transplantation (CLN-). Normal hosts (CLN+), splenectomized mice (Sp-), and those without either CLNs or spleen (CLN-/Sp-) served as comparison groups. To determine the contribution of CLNs to alloimmunity more directly, CLN- mice were reconstituted by grafting LNs from other BALB/c mice to their cervical lymphatic chains, thus deriving CLN-/+ mice. Tetramethyl rhodamine isothiocyanate’s (TRITC) flow to draining CLNs was used as a measure of afferent lymph flow. Graft survival and allospecific delayed-type hypersensitivity (DTH) were used as measures of alloreactivity.
RESULTS. Fifty percent of normal control and 12% of Sp- hosts accepted the allografts. In contrast, 100% of CLN- and 88% of CLN-/Sp- hosts accepted allografts indefinitely (P < 0.01). Additionally, all CLN- hosts failed to demonstrate allospecific DTH (P < 0.001). CLN-/+ mice reconstituted with LN from naïve animals showed graft survival rates and DTH responses that were indistinguishable from those of naïve CLN+ mice. Of particular interest, however, is that mice reconstituted with CLNs from hosts with rejected corneal grafts had swift rejection of subsequent corneal grafts and exhibited strong donor-specific DTH. In contrast, mice reconstituted with CLNs from hosts with accepted corneal grafts showed rejection of subsequent corneal grafts in a manner that was indistinguishable from rejection in naïve CLN+ hosts.
CONCLUSIONS. Draining CLNs play a critical role in allosensitization and rejection. In contrast to the spleen, draining CLNs do not appear to play a critical role in tolerance induction in corneal transplantation.
This article has been cited by other articles:
|
|
 |
|
  B. O. Bachmann, F. Bock, S. J. Wiegand, K. Maruyama, M. R. Dana, F. E. Kruse, E. Luetjen-Drecoll, and C. Cursiefen Promotion of Graft Survival by Vascular Endothelial Growth Factor A Neutralization After High-Risk Corneal Transplantation Arch Ophthalmol, January 1, 2008; 126(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dietrich, J. Onderka, F. Bock, F. E. Kruse, D. Vossmeyer, R. Stragies, G. Zahn, and C. Cursiefen Inhibition of Inflammatory Lymphangiogenesis by Integrin {alpha}5 Blockade Am. J. Pathol., July 1, 2007; 171(1): 361 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, S. Huq, H. Gardner, A. R. de Fougerolles, S. Barabino, and M. R. Dana Very Late Antigen 1 Blockade Markedly Promotes Survival of Corneal Allografts Arch Ophthalmol, June 1, 2007; 125(6): 783 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Lee, H. Kim, N. S. Wang, P. M. Bungay, B. C. Gilger, P. Yuan, J. Kim, K. G. Csaky, and M. R. Robinson A Pharmacokinetic and Safety Evaluation of an Episcleral Cyclosporine Implant for Potential Use in High-Risk Keratoplasty Rejection Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2023 - 2029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hamrah, S. Yamagami, Y. Liu, Q. Zhang, S. S. Vora, B. Lu, C. J. Gerard, and M. R. Dana Deletion of the Chemokine Receptor CCR1 Prolongs Corneal Allograft Survival Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1228 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, C. Cursiefen, S. Barabino, Q. Zhang, and M. R. Dana Novel Expression and Characterization of Lymphatic Vessel Endothelial Hyaluronate Receptor 1 (LYVE-1) by Conjunctival Cells Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4536 - 4540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Jessup, H. M. Brereton, P. J. Sykes, M. A. Thiel, D. J. Coster, and K. A. Williams Local Gene Transfer to Modulate Rat Corneal Allograft Rejection Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1675 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huq, Y. Liu, G. Benichou, and M. R. Dana Relevance of the Direct Pathway of Sensitization in Corneal Transplantation Is Dictated by the Graft Bed Microenvironment J. Immunol., October 1, 2004; 173(7): 4464 - 4469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Plskova, L Kuffova, M Filipec, V Holan, and J V Forrester Quantitative evaluation of the corneal endothelium in the mouse after grafting Br. J. Ophthalmol., September 1, 2004; 88(9): 1209 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cursiefen, J. Cao, L. Chen, Y. Liu, K. Maruyama, D. Jackson, F. E. Kruse, S. J. Wiegand, M. R. Dana, and J. W. Streilein Inhibition of Hemangiogenesis and Lymphangiogenesis after Normal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2666 - 2673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Camelo, A. Shanley, A. S. P. Voon, and P. G. McMenamin The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye J. Immunol., May 1, 2004; 172(9): 5388 - 5395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Dana Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727. [Full Text] [PDF]
|
|
|
|
|
|
P. Hamrah, Y. Liu, Q. Zhang, and M. R. Dana Alterations in Corneal Stromal Dendritic Cell Phenotype and Distribution in Inflammation Arch Ophthalmol, August 1, 2003; 121(8): 1132 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hamrah, L. Chen, Q. Zhang, and M. R. Dana Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells Am. J. Pathol., July 1, 2003; 163(1): 57 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cursiefen, U. Schlotzer-Schrehardt, M. Kuchle, L. Sorokin, S. Breiteneder-Geleff, K. Alitalo, and D. Jackson Lymphatic Vessels in Vascularized Human Corneas: Immunohistochemical Investigation Using LYVE-1 and Podoplanin Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2127 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, P. Hamrah, Q. Zhang, A. W. Taylor, and M. R. Dana Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II-positive Dendritic Cells Derived from MHC Class II-negative Grafts J. Exp. Med., January 22, 2002; 195(2): 259 - 268. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
